HealthTree Logo
search more_vert
person Sign In / Create Account

Nina Delaney , MD

Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Associate Professor of Oncology

Clinical Expertise


  • Chemotherapy Induced Peripheral Neuropathy
  • Hodgkin's Disease
  • Medical Oncology
  • Non-Hodgkin's Lymphoma (NHL)
  • Palliative Care


  • Lymphoma
  • AIDS-related malignancies
  • Palliative/supportive care
  • Chemotherapy induced peripheral neuropathy
  • CIPN


Dr. Nina Wagner-Johnston is Associate Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University.

Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015.

Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri.

Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy.  

Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine.  She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee.


John Hopkins University School Of Medicine: 1550 Orleans St, Baltimore, MD 21287, USA